Hing Wong
Founder at HCW BIOLOGICS INC.
Net worth: 28 M $ as of 30/03/2024
Profile
Hing C.
Wong was the founder of Altor BioScience Corp.
(founded in 2002), Sunol Molecular Corp.
(founded in 1996), and HCW Biologics Inc. (founded in 2018) where he held the titles of President, Chief Executive Officer & Director, Chairman & Chief Executive Officer, and Chief Executive Officer, Secretary & Director respectively.
He previously worked as Director-Biology Skills Center at Baxter International, Inc. from 1992 to 1996, Director-Microbial Genetics Department at Chiron Corp.
from 1983 to 1992, and Director-Microbial Genetics at Cetus Corp.
from 1983 to 1992.
He also served as Chief Executive Officer at NantCell, Inc. and as a Director at Biosynexus, Inc. He has also served as a Trustee at The Cancer Research Foundation, Inc. and Rumbaugh-Goodwin Institute For Cancer Research, Inc. Dr. Wong holds a doctorate degree from the University of Massachusetts.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
HCW BIOLOGICS, INC.
44.63% | 19/02/2024 | 16,054,156 ( 44.63% ) | 28 M $ | 30/03/2024 |
Hing Wong active positions
| Companies | Position | Start |
|---|---|---|
| HCW BIOLOGICS INC. | Founder | 01/04/2018 |
Former positions of Hing Wong
| Companies | Position | End |
|---|---|---|
NantCell, Inc.
 NantCell, Inc. Pharmaceuticals: MajorHealth Technology NantCell, Inc. focuses on treating immunology diseases. It offers cell-based treatments at the molecular level. The firm develops molecularly designed drugs for genomics and proteomics and identify patients and their tumor signature at the granular cellular, DNA and protein levels. The company was founded by Patrick Soon-Shiong in 2014 and is headquartered in Culver City, CA. | Chief Executive Officer | 28/02/2018 |
Altor BioScience Corp.
 Altor BioScience Corp. Pharmaceuticals: MajorHealth Technology Altor BioScience Corp. operates as a biopharmaceutical company which develops therapeutic products for the treatment of cancer. Its product candidates include ALT-801, a T-cell receptor-targeted immunotherapeutic for cancer and ALT-836, a monoclonal antibody-based tissue factor antagonist treatment of patients with acute respiratory distress syndrome and acute lung injury. The company was founded by Hing C. Wong in 2002 and is headquartered in Miramar, FL. | Founder | 31/07/2017 |
Sunol Molecular Corp.
 Sunol Molecular Corp. Pharmaceuticals: MajorHealth Technology Part of ImmunityBio, Inc., Sunol Molecular Corp. is a private company that develops gel therapeutics to treat disorders associated with the human tissue factor. The company is based in Miramar, FL. The company was founded by Hing C. Wong, Jon Weidanz, Peter R. Rhode. Sunol Molecular was acquired by Altor BioScience Corp., part of ImmunityBio, Inc. from August 01, 2017 on March 25, 2005. | Chief Executive Officer | 31/12/2001 |
| BAXTER INTERNATIONAL INC. | Corporate Officer/Principal | 31/12/1995 |
| Cetus Corp. | Corporate Officer/Principal | 31/12/1991 |
Training of Hing Wong
| University of Massachusetts | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| BAXTER INTERNATIONAL INC. | Health Technology |
| HCW BIOLOGICS INC. | Health Technology |
| Private companies | 8 |
|---|---|
Chiron Corp.
 Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | Health Technology |
Altor BioScience Corp.
Altor BioScience Corp. Pharmaceuticals: MajorHealth Technology Altor BioScience Corp. operates as a biopharmaceutical company which develops therapeutic products for the treatment of cancer. Its product candidates include ALT-801, a T-cell receptor-targeted immunotherapeutic for cancer and ALT-836, a monoclonal antibody-based tissue factor antagonist treatment of patients with acute respiratory distress syndrome and acute lung injury. The company was founded by Hing C. Wong in 2002 and is headquartered in Miramar, FL. | Health Technology |
| Cetus Corp. | Health Technology |
Biosynexus, Inc.
 Biosynexus, Inc. Pharmaceuticals: MajorHealth Technology Biosynexus, Inc. develops and markets pharmaceutical products. The company is headquartered in Rockville, MD. | Health Technology |
Sunol Molecular Corp.
Sunol Molecular Corp. Pharmaceuticals: MajorHealth Technology Part of ImmunityBio, Inc., Sunol Molecular Corp. is a private company that develops gel therapeutics to treat disorders associated with the human tissue factor. The company is based in Miramar, FL. The company was founded by Hing C. Wong, Jon Weidanz, Peter R. Rhode. Sunol Molecular was acquired by Altor BioScience Corp., part of ImmunityBio, Inc. from August 01, 2017 on March 25, 2005. | Health Technology |
The Cancer Research Foundation, Inc.
 The Cancer Research Foundation, Inc. Hospital/Nursing ManagementHealth Services The Cancer Research Foundation provides cancer treatment services. Its funding programs include Bernice Goldblatt fellowship, young investigator awards, Fletcher scholars program, and supported researchers. The company was founded by Maurice Goldblatt in 1954 and is headquartered in Chicago, IL. | Health Services |
| Rumbaugh-Goodwin Institute For Cancer Research, Inc. | |
NantCell, Inc.
NantCell, Inc. Pharmaceuticals: MajorHealth Technology NantCell, Inc. focuses on treating immunology diseases. It offers cell-based treatments at the molecular level. The firm develops molecularly designed drugs for genomics and proteomics and identify patients and their tumor signature at the granular cellular, DNA and protein levels. The company was founded by Patrick Soon-Shiong in 2014 and is headquartered in Culver City, CA. | Health Technology |
- Stock Market
- Insiders
- Hing Wong
